Analyze Diet
Journal of veterinary pharmacology and therapeutics1981; 4(2); 147-156; doi: 10.1111/j.1365-2885.1981.tb00724.x

The pharmacokinetics of meclofenamic acid in the horse.

Abstract: The pharmacokinetics of meclofenamic acid were studied in Thoroughbred horses and in ponies. After intravenous (i.v.) administration of either 2 mg/kg or 4 mg/kg sodium meclofenamate the elimination half-life was of the order of 0.9 h while the volume of distribution was found to be 0.128 litre/kg. Elimination was in accordance with a one-compartment model. Following oral administration of either meclofenamic acid (4 mg/kg) or sodium meclofenamate (4 mg/kg) a much longer terminal half-life than that calculated for Kel from i.v. data was found. This anomaly indicated that the 'flip-flop' phenomenon was present, i.e. Ka exceeded Kel. More rapid and higher peak levels occurred following sodium meclofenamate than meclofenamic acid, although total bioavailability was similar. Studies in ponies with meclofenamic acid showed a lower absorption than that found in Thoroughbreds. Overnight fasting before meclofenamic acid administration did not alter the rate or extent of absorption. Intramuscular administration of sodium meclofenamate resulted in low plasma concentrations and after 25 h only 46% of the drug had been absorbed.
Publication Date: 1981-06-01 PubMed ID: 7349327DOI: 10.1111/j.1365-2885.1981.tb00724.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the behavior of a drug, meclofenamic acid, in Thoroughbred horses and ponies following oral, intravenous, and intramuscular administration. This was carried out in order to better understand how the drug is absorbed, distributed, and eliminated in these animals.

Study Aim and Methodology

  • The research was intended to understand how meclofenamic acid behaves inside the body of Thoroughbreds and ponies. This involves understanding how quickly and efficiently the drug is absorbed into the bloodstream, how it is distributed within the body, and also how it is eliminated.
  • The study was carried out by administering the drug in two forms – as meclofenamic acid and sodium meclofenamate, and through three routes – orally, intravenously, and intramuscularly. The doses were either 2 mg/kg or 4 mg/kg.

Key Findings

  • The half-life for the elimination of the drug was approximately 0.9 hours after intravenous administration. The volume of distribution was 0.128 litre/kg, suggesting that the drug is rapidly distributed through the body.
  • The researchers found that elimination was in accordance with a one-compartment model, suggesting that the drug does not undergo extensive distribution to other body compartments beyond the blood.
  • After oral administration, the terminal half-life was significantly longer than that calculated for the elimination rate constant (Kel) from intravenous data. This discrepancy indicated the presence of the ‘flip-flop’ phenomenon, where the absorption rate constant (Ka) is higher than Kel.
  • Sodium meclofenamate resulted in quicker and higher peak levels than meclofenamic acid, although the total bioavailability was similar for both. This would suggest that sodium meclofenamate may be more easily absorbed into the bloodstream compared to meclofenamic acid.
  • In ponies, meclofenamic acid showed a lower absorption than that in Thoroughbreds.
  • Fasting overnight prior to administering meclofenamic acid did not affect the rate or extent of absorption, indicating that the drug’s behavior is not significantly influenced by food intake.
  • Following intramuscular administration of sodium meclofenamate, plasma concentrations were low and even after 25 hours, only 46% of the drug had been absorbed. This suggests that this drug may not be effectively absorbed when administered intramuscularly.

Cite This Article

APA
Snow DH, Baxter P, Whiting B. (1981). The pharmacokinetics of meclofenamic acid in the horse. J Vet Pharmacol Ther, 4(2), 147-156. https://doi.org/10.1111/j.1365-2885.1981.tb00724.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 4
Issue: 2
Pages: 147-156

Researcher Affiliations

Snow, D H
    Baxter, P
      Whiting, B

        MeSH Terms

        • Administration, Oral
        • Animals
        • Blood Proteins / metabolism
        • Horses / metabolism
        • Injections, Intramuscular
        • Injections, Intravenous
        • Kinetics
        • Meclofenamic Acid / administration & dosage
        • Meclofenamic Acid / blood
        • Meclofenamic Acid / metabolism
        • Protein Binding
        • ortho-Aminobenzoates / metabolism

        Citations

        This article has been cited 2 times.
        1. Garrison KL, Sahin S, Benet LZ. Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS.. J Pharm Sci 2015 Sep;104(9):3229-35.
          doi: 10.1002/jps.24505pubmed: 26010239google scholar: lookup
        2. Yáñez JA, Remsberg CM, Sayre CL, Forrest ML, Davies NM. Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.. Ther Deliv 2011 May;2(5):643-72.
          doi: 10.4155/tde.11.19pubmed: 21837267google scholar: lookup